Related Experiment Video
Updated: Aug 12, 2026

07:25
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
D1 dopamine receptor activity is not altered by a mutation in the first intracellular loop
H Jin1, S Nip, B F O'Dowd
1Addiction Research Foundation, Toronto, Ontario, Canada.
Biochimica Et Biophysica Acta
|April 30, 1998
Summary
Mutations in the first intracellular loop of G protein-coupled receptors (GPCRs) can alter function. A specific mutation in melanocyte-stimulating hormone receptors causes constitutive activity, but the equivalent mutation in dopamine D1 receptors does not affect their coupling.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The first intracellular loop of G protein-coupled receptors (GPCRs) is a poorly understood region.
- Mutations in this loop can variably affect receptor-G protein coupling.
- A Ser69Leu mutation in melanocyte-stimulating hormone (MSH) receptors leads to constitutive activity.
Purpose of the Study:
- To investigate the role of the serine residue at position 56 in the first intracellular loop of the human dopamine D1 receptor (D1DR).
- To determine if a Ser56Leu mutation in D1DR affects receptor-G protein coupling, similar to observations in MSH receptors.
Main Methods:
- Site-directed mutagenesis was used to create the Ser56Leu mutation in the human D1DR.
- The ability of the mutated D1DR to bind ligand was assessed.
- Receptor-G protein coupling efficiency was evaluated.
Main Results:
- The Ser56Leu mutation in D1DR did not alter ligand binding affinity.
- The mutated D1DR exhibited normal coupling to G proteins.
- Unlike MSH receptors, the equivalent mutation in D1DR did not confer constitutive activity or enhanced signaling.
Conclusions:
- The serine residue at position 56 in the first intracellular loop of human D1DR is not critical for receptor-G protein coupling.
- The functional consequences of mutations in the first intracellular loop of GPCRs are receptor-specific.
- Dopamine D1 receptors may have distinct mechanisms for regulating signaling compared to MSH receptors.
Related Concept Videos
Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

